ArticleScientific reports2025
Nanoparticle modified paper-based analytical sensor for calcium determination in human nasal secretions and its association with olfactory dysfunction.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Olfactory dysfunction has emerged as an important clinical issue, particularly following the global rise in post-viral anosmia. Recent research suggests an association between altered calcium homeostasis and poor olfactory signaling, but there is no validated method for assessing calcium levels in nasal secretions. Herein, a novel paper-based electrochemical sensor for the direct determination of free calcium ions in nasal secretions, providing potential diagnostic biomarker in olfactory dysfunction. The sensor integrates multi-walled carbon nanotubes, carbon dots synthesized from guava fruit, and the calcium-selective ionophore ETH 1001 to improve conductivity and selectivity. It exhibits a Nernstian response with a slope of 29.14 ± 0.3 mV/decade over a linear range from 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.